| Pathway | Proteins Involved |
| 1- and 2-Methylnaphthalene degradation | CO897648 |
| Adherens junction | CV067459 |
| Alanine, aspartate and glutamate metabolism | Contig395 |
| Disease | Contig359; Contig255; CO961129, CO961129; CO897768; Contig255; Contig27; CV067459, CV067459; CV067459; CV067459;CV067459 |
| Arginine and proline metabolism | Contig395; Contig727 |
| Base excision repair | EY194648 |
| Benzoate degradation via CoA ligation | CO897648 |
| Biosynthesis of unsaturated fatty acids | ES584529 |
| Butanoate metabolism | EY193427 |
| Calcium signaling pathway | Contig359; Contig27; CO897768 |
| Caprolactam degradation | EY193427 |
| Cardiac muscle contraction | CO961129; Contig255 |
| Cell cycle | CO897592; Contig890 |
| Chaperones and folding catalysts | CO960951; Contig510 |
| Chromosome | CV067459; EY190619; Contig966; CO961479; Contig890; Contig1037 |
| Citrate cycle (TCA cycle) | ES584523 |
| Cytoskeleton proteins | CV067459; CV130254; CO780670 |
| D-Glutamine and D-glutamate metabolism | Contig395 |
| DNA repair and recombination proteins | EY194648; EY191428; Contig961 |
| DNA replication proteins | EY191428 |
| Drug metabolism - cytochrome P450 | Contig931 |
| Endocytosis | EY192611 |
| Ethylbenzene degradation | CO897648 |
| Fatty acid elongation in mitochondria | EY193427 |
| Fatty acid metabolism | EY193427 |
| Focal adhesion | CV067459 |
| Fructose and mannose metabolism | Contig386 |
| General function | Contig801 |
| Geraniol degradation | EY193427 |
| Glutathione metabolism | EY190395; Contig931 |
| Glycerophospholipid metabolism | CO897648 |
| Glycolysis / Gluconeogenesis | ES584523 |
| GTP-binding proteins | CO897717 |
| Leukocyte transendothelial migration | CV067459 |
| Limonene and pinene degradation | CO897648 |
| Lipid biosynthesis proteins | ES584529 |
| Lysine degradation | EY193427 |
| Meiosis - yeast | Contig890 |
| Metabolism of xenobiotics by cytochrome | Contig931 |
| Neurotrophin signaling pathway | CO897592 |
| Nitrogen metabolism | Contig395 |
| Oocyte meiosis | CO897592; Contig890 |
| Oxidative phosphorylation | CO961129; Contig255 |
| Pantothenate and CoA biosynthesis | CO897972 |
| Pathogenic Escherichia coli infection | CV067459 |
| Peptidases | Contig816; Contig1130; Contig510; EY190619 |
| Phenylalanine metabolism | CO897648 |
| Porphyrin and chlorophyll metabolism | Contig57 |
| Peroxisome proliferator-activated receptors signaling pathway | ES584529 |
| Progesterone-mediated oocyte maturation | Contig890 |
| Purine metabolism | Contig961 |
| Pyrimidine metabolism | Contig961 |
| Pyruvate metabolism | ES584523 |
| Receptors and channels | EY190775 |
| Regulation of actin cytoskeleton | CV067459 |
| Renin-angiotensin system | Contig51 |
| Retinol metabolism | EY193842 |
| Ribosome | Contig1040; Contig681; Contig971; Contig963; Contig1133; Contig1082; Contig1006; Contig1117; Contig1028; EY190948 |
| RNA degradation | Contig201 |
| RNA polymerase | Contig961 |
| Lysosyme or vesicle fusion proteins | EY193828 |
| Spliceosome | CO897660 |
| Starch and sucrose metabolism | GW395922 |
| Systemic lupus erythematosus | Contig966;Contig1037 |
| Tight junction | CV067459 |
| Transcription factors | Contig1100; Contig1000; CO897864 |
| Translation factors | Contig199; Contig1056 |
| Tryptophan metabolism | EY193427 |
| Tyrosine metabolism | CO897648 |
| Ubiquitin mediated proteolysis | EY192611; Contig890 |
| Ubiquitin system | CO961157; EY192611; EY190619; Contig1130; Contig890 |
| Valine, leucine and isoleucine degradation | EY193427; CO897972; CO897972 |